Effectiveness of testing, contact tracing and isolation interventions among the general population on reducing transmission of SARS-CoV-2: a systematic review.
Contact tracing
Epidemics
Infectious diseases
SARS-CoV-2
Testing
Transmission contol
Journal
Philosophical transactions. Series A, Mathematical, physical, and engineering sciences
ISSN: 1471-2962
Titre abrégé: Philos Trans A Math Phys Eng Sci
Pays: England
ID NLM: 101133385
Informations de publication
Date de publication:
09 Oct 2023
09 Oct 2023
Historique:
medline:
25
8
2023
pubmed:
24
8
2023
entrez:
23
8
2023
Statut:
ppublish
Résumé
We conducted a systematic literature review of general population testing, contact tracing, case isolation and contact quarantine interventions to assess their effectiveness in reducing SARS-CoV-2 transmission, as implemented in real-world settings. We designed a broad search strategy and aimed to identify peer-reviewed studies of any design provided there was a quantitative measure of effectiveness on a transmission outcome. Studies that assessed the effect of testing or diagnosis on disease outcomes via treatment, but did not assess a transmission outcome, were not included. We focused on interventions implemented among the general population rather than in specific settings; these were from anywhere in the world and published any time after 1 January 2020 until the end of 2022. From 26 720 titles and abstracts, 1181 were reviewed as full text, and 25 met our inclusion criteria. These 25 studies included one randomized control trial (RCT) and the remaining 24 analysed empirical data and made some attempt to control for confounding. Studies included were categorized by the type of intervention: contact tracing (seven studies); specific testing strategies (12 studies); strategies for isolating cases/contacts (four studies); and 'test, trace, isolate' (TTI) as a part of a package of interventions (two studies). None of the 25 studies were rated at low risk of bias and many were rated as serious risk of bias, particularly due to the likely presence of uncontrolled confounding factors, which was a major challenge in assessing the independent effects of TTI in observational studies. These confounding factors are to be expected from observational studies during an on-going pandemic, when the emphasis was on reducing the epidemic burden rather than trial design. Findings from these 25 studies suggested an important public health role for testing followed by isolation, especially where mass and serial testing was used to reduce transmission. Some of the most compelling analyses came from examining fine-grained within-country data on contact tracing; while broader studies which compared behaviour between countries also often found TTI led to reduced transmission and mortality, this was not universal. There was limited evidence for the benefit of isolation of cases/contacts away from the home environment. One study, an RCT, showed that daily testing of contacts could be a viable strategy to replace lengthy quarantine of contacts. Based on the scarcity of robust empirical evidence, we were not able to draw any firm quantitative conclusions about the quantitative impact of TTI interventions in different epidemic contexts. While the majority of studies found that testing, tracing and isolation reduced transmission, evidence for the scale of this impact is only available for specific scenarios and hence is not necessarily generalizable. Our review therefore emphasizes the need to conduct robust experimental studies that help inform the likely quantitative impact of different TTI interventions on transmission and their optimal design. Work is needed to support such studies in the context of future emerging epidemics, along with assessments of the cost-effectiveness of TTI interventions, which was beyond the scope of this review but will be critical to decision-making. This article is part of the theme issue 'The effectiveness of non-pharmaceutical interventions on the COVID-19 pandemic: the evidence'.
Identifiants
pubmed: 37611628
doi: 10.1098/rsta.2023.0131
pmc: PMC10446909
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20230131Subventions
Organisme : Medical Research Council
ID : MR/S020462/1
Pays : United Kingdom
Références
Lancet Public Health. 2022 Mar;7(3):e259-e273
pubmed: 35180434
Nat Phys. 2021 May;17:652-658
pubmed: 34367312
Public Health. 2020 Dec;189:54-59
pubmed: 33160088
Am J Trop Med Hyg. 2020 Dec;103(6):2400-2411
pubmed: 33124541
Nat Rev Genet. 2021 Jul;22(7):415-426
pubmed: 33948037
PLoS One. 2020 Dec 29;15(12):e0244177
pubmed: 33373384
China Econ Rev. 2022 Oct;75:101849
pubmed: 35971424
Elife. 2021 Feb 05;10:
pubmed: 33543709
Eur J Epidemiol. 2023 Mar;38(3):243-266
pubmed: 36795349
J Public Health (Oxf). 2021 Sep 22;43(3):499-507
pubmed: 33554257
BMC Infect Dis. 2021 Aug 18;21(1):828
pubmed: 34407759
Nat Commun. 2022 Aug 10;13(1):4700
pubmed: 35948531
Nature. 2021 Jun;594(7863):408-412
pubmed: 33979832
Int J Environ Res Public Health. 2021 Feb 22;18(4):
pubmed: 33671746
Age Ageing. 2021 Nov 10;50(6):1868-1875
pubmed: 34272866
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
J R Soc Med. 2020 Sep;113(9):335-338
pubmed: 32910870
Nat Commun. 2021 Jan 7;12(1):356
pubmed: 33414470
Lancet. 2021 Oct 2;398(10307):1217-1229
pubmed: 34534517
BMJ. 2022 Nov 23;379:e071374
pubmed: 36418047
Clin Infect Dis. 2021 May 4;72(9):e334-e342
pubmed: 32738143
BMJ Open. 2022 Feb 10;12(2):e058060
pubmed: 35144956
AIMS Microbiol. 2020 Aug 26;6(3):280-304
pubmed: 33134745
BMJ. 2020 Sep 21;370:m3678
pubmed: 32958475
PLoS One. 2021 Jul 15;16(7):e0254012
pubmed: 34264966
Nat Med. 2020 Oct;26(10):1616-1622
pubmed: 32770169
Sci Rep. 2022 Nov 14;12(1):19538
pubmed: 36376420
Sci Rep. 2021 May 19;11(1):10605
pubmed: 34012040
Philos Trans A Math Phys Eng Sci. 2023 Oct 9;381(2257):20230131
pubmed: 37611628
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
PLoS One. 2022 Nov 9;17(11):e0274407
pubmed: 36350805
PLoS One. 2021 Mar 4;16(3):e0246987
pubmed: 33661926
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6146-51
pubmed: 15071187
Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):
pubmed: 34187879
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200267
pubmed: 34053253
BMJ. 2021 Jul 6;374:n1637
pubmed: 34230058
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200270
pubmed: 34053257
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33):
pubmed: 34385318
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
BMC Med. 2021 Feb 5;19(1):40
pubmed: 33541353
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
J Clin Epidemiol. 2021 Feb;130:13-22
pubmed: 33068715
J Travel Med. 2021 Feb 23;28(2):
pubmed: 33410482
Am J Prev Med. 1999 Oct;17(3):230-42
pubmed: 10987639
EClinicalMedicine. 2021 Aug;38:101011
pubmed: 34278276
BMC Public Health. 2022 Oct 1;22(1):1842
pubmed: 36183075
Lancet Reg Health West Pac. 2023 Jan;30:100616
pubmed: 36248767
J R Soc Med. 2021 Jun;114(6):290-294
pubmed: 33870766
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Lancet Digit Health. 2020 Dec;2(12):e658-e666
pubmed: 33078140
BMJ. 2021 Mar 31;372:n608
pubmed: 33789843
Eur J Epidemiol. 2021 Jun;36(6):629-640
pubmed: 34114189
Nat Med. 2021 Mar;27(3):361-362
pubmed: 33589822
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Sustain Cities Soc. 2022 May;80:103772
pubmed: 35186668
BMC Public Health. 2022 Jun 13;22(1):1177
pubmed: 35698094
PLoS One. 2022 Jul 22;17(7):e0271586
pubmed: 35867692
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
PLoS Comput Biol. 2022 May 27;18(5):e1010158
pubmed: 35622860
Public Health. 2021 Sep;198:123-128
pubmed: 34416575
Lancet Reg Health Eur. 2021 Jul;6:100107
pubmed: 34002172
Nat Hum Behav. 2020 Dec;4(12):1303-1312
pubmed: 33199859
Science. 2021 May 7;372(6542):635-641
pubmed: 33758017
Lancet Infect Dis. 2022 Mar;22(3):341-348
pubmed: 34843662
Sci Rep. 2021 Jan 25;11(1):2145
pubmed: 33495491
Int J Environ Res Public Health. 2020 Dec 30;18(1):
pubmed: 33396689
Front Public Health. 2021 Oct 05;9:700811
pubmed: 34692619
Talanta. 2022 Jul 1;244:123409
pubmed: 35390680
Lancet Respir Med. 2022 Nov;10(11):1074-1085
pubmed: 36228640
Lancet Public Health. 2020 Nov;5(11):e612-e623
pubmed: 33065023
Lancet Infect Dis. 2021 Oct;21(10):1365-1372
pubmed: 34051886
Curr Infect Dis Rep. 2022;24(10):129-145
pubmed: 35965881
BMJ. 2020 Jan 16;368:l6890
pubmed: 31948937
Lancet Reg Health Eur. 2022 Aug;19:100446
pubmed: 35791373